IL313411A - Designed repeat domains with dual binding specificity and their use - Google Patents

Designed repeat domains with dual binding specificity and their use

Info

Publication number
IL313411A
IL313411A IL313411A IL31341124A IL313411A IL 313411 A IL313411 A IL 313411A IL 313411 A IL313411 A IL 313411A IL 31341124 A IL31341124 A IL 31341124A IL 313411 A IL313411 A IL 313411A
Authority
IL
Israel
Prior art keywords
binding specificity
repeat regions
dual binding
designed repeat
designed
Prior art date
Application number
IL313411A
Other languages
English (en)
Hebrew (he)
Original Assignee
Molecular Partners Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Partners Ag filed Critical Molecular Partners Ag
Publication of IL313411A publication Critical patent/IL313411A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL313411A 2021-12-14 2022-12-14 Designed repeat domains with dual binding specificity and their use IL313411A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21214519 2021-12-14
PCT/EP2022/085794 WO2023110983A1 (en) 2021-12-14 2022-12-14 Designed repeat domains with dual binding specificity and their use

Publications (1)

Publication Number Publication Date
IL313411A true IL313411A (en) 2024-08-01

Family

ID=80112165

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313411A IL313411A (en) 2021-12-14 2022-12-14 Designed repeat domains with dual binding specificity and their use

Country Status (9)

Country Link
US (1) US20250042957A1 (cg-RX-API-DMAC7.html)
EP (1) EP4447990A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025504625A (cg-RX-API-DMAC7.html)
KR (1) KR20240122764A (cg-RX-API-DMAC7.html)
CN (1) CN118354784A (cg-RX-API-DMAC7.html)
AU (1) AU2022413461A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239407A1 (cg-RX-API-DMAC7.html)
IL (1) IL313411A (cg-RX-API-DMAC7.html)
WO (1) WO2023110983A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
WO2025050026A1 (en) * 2023-08-30 2025-03-06 The Board Of Trustees Of The Leland Stanford Junior University Polypeptides for inducible and repressible binding to targets of interest and methods of use
WO2025146490A1 (en) * 2024-01-05 2025-07-10 Molecular Partners Ag Recombinant cd117 binding proteins and their use
CN122438868A (zh) 2024-01-05 2026-07-21 分子合作伙伴股份公司 多特异性结合蛋白
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2026093563A2 (en) 2024-10-31 2026-05-07 Molecular Partners Ag Multispecific binding proteins and their use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
WO2003078575A2 (en) 2002-03-11 2003-09-25 The Johns Hopkins University Molecular switches and methods for making and using the same
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
WO2015067302A1 (en) 2013-11-05 2015-05-14 Ecole Polytechnique Federale De Lausanne (Epfl) Sensor molecules and uses thereof
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
WO2018017827A1 (en) * 2016-07-22 2018-01-25 Fred Hutchinson Cancer Research Center Bi-specific molecule for cell-specific notch inhibition and related methods and compositions
MY196882A (en) 2016-09-22 2023-05-08 Molecular Partners Ag Recombinant binding proteins and their use
WO2019089592A1 (en) 2017-10-31 2019-05-09 The General Hospital Corporation Molecular switch-mediated control of engineered cells
WO2020190852A2 (en) 2019-03-17 2020-09-24 Jorge Fallas Topological control of receptor signaling using synthetic homo- and hetero-dimeric cytokine mimetics
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
IL298168A (en) * 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
AU2021403658A1 (en) 2020-12-16 2023-06-29 Molecular Partners Ag Recombinant cd3 binding proteins and their use

Also Published As

Publication number Publication date
EP4447990A1 (en) 2024-10-23
AU2022413461A1 (en) 2024-06-06
JP2025504625A (ja) 2025-02-14
US20250042957A1 (en) 2025-02-06
WO2023110983A1 (en) 2023-06-22
KR20240122764A (ko) 2024-08-13
CA3239407A1 (en) 2023-06-22
CN118354784A (zh) 2024-07-16

Similar Documents

Publication Publication Date Title
IL287479A (en) Cd19 binding molecules and uses thereof
IL284280A (en) Improved antibody-oligonucleotide conjugate
EP3913001A4 (en) ANTI-CLD18A2 NANOBODY AND ITS USE
IL272524A (en) Clec9a binding agents and use thereof
EP3939266A4 (en) LIMITED AND ADAPTED APPLICATIONS OF COMBINED INTER AND INTRA PREDICTION MODES
DK3737765T4 (da) Forstærkede immunceller med dobbelt shrna og sammensætning dermed
IL299867A (en) Cd19 binding molecules and uses thereof
DK2786762T3 (da) Kovalente diabodies og anvendelser deraf
EP3277711C0 (en) Designed ankyrin repeat domains with binding specificity for serum albumin
EP4129662A4 (en) Biosensor
DK3922266T3 (da) Toll-like-receptor-7- eller -8-agonist-kolesterolkompleks og anvendelse deraf
EP4413809A4 (en) SIDELINK TRANSFER AND ROUND TRIP TIME POSITIONING
DK3908570T3 (da) Ketaminpamoat og andevendelse deraf
EP4076526A4 (en) Novel ddr1 antibodies and uses thereof
DK3892621T3 (da) Haloallylaminforbindelser og anvendelse deraf
EP4459718A4 (en) BINDING AND RELATED USE
DK3583126T3 (da) Multispecifikke bindingsmolekyler med specificitet for dystroglycan og laminin-2
EP3962814C0 (fr) Aéronef spatial à conception et architecture optimisées
EP4441084A4 (en) VARIANTS OF IL-10 AND THEIR USES
EP4165042A4 (en) TRICYCLIC PSYCHOPLASTOGENS AND THEIR USES
EP4246139A4 (en) BIOSENSOR
HUE071208T2 (hu) Könyv és játék kombináció
EP4504190A4 (en) OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES
IL308375A (en) Anti-tmprss6 antibodies and uses thereof
EP4198040C0 (de) Pt-dpephos-iod-komplex und pt-dpephos-brom-komplex